|
Volumn 691, Issue 1, 1997, Pages 95-104
|
Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry
a a a a |
Author keywords
5 Chloro 2,4 dihydroxypyridine; 5 Fluorouracil; Potassium oxonate; S 1; Tegafur
|
Indexed keywords
5 CHLORO 2,4 DIHYDROXYPYRIDINE;
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
OXONIC ACID;
TEGAFUR;
ACCURACY;
ARTICLE;
CALIBRATION;
CONTROLLED STUDY;
DERIVATIZATION;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG STABILITY;
DRUG URINE LEVEL;
GAS CHROMATOGRAPHY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
HUMAN TISSUE;
MASS SPECTROMETRY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REPRODUCIBILITY;
TECHNIQUE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG COMBINATIONS;
DRUG STABILITY;
FLUOROURACIL;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HUMANS;
HYDROGEN-ION CONCENTRATION;
KINETICS;
MAGNETIC RESONANCE SPECTROSCOPY;
OXONIC ACID;
PYRIDINES;
SENSITIVITY AND SPECIFICITY;
TEGAFUR;
|
EID: 0030976586
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(96)00429-X Document Type: Article |
Times cited : (95)
|
References (14)
|